Clinical trial
Rituximab in the Treatment of HIV Associated Multicentric Castleman Disease…
NCT00127569 · French National Agency for Research on AIDS and Viral Hepatitis, Other · Terminated
Key facts
| NCT number | NCT00127569 |
|---|---|
| Title | Rituximab in the Treatment of HIV Associated Multicentric Castleman Disease Dependent on Chemotherapy |
| Official title | Multicenter, Phase II Trial Assessing the Efficacy of Rituximab in HIV Infected Patients With Multicentric Castleman Disease Dependent on Chemotherapy (ANRS 117 Study, CastlemaB) |
| Lead sponsor | French National Agency for Research on AIDS and Viral Hepatitis, Other |
| Collaborators | Hoffmann-La Roche Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | HIV Infections, Giant Lymph Node Hyperplasia |
| Intervention type | Drug |
| Interventions | Rituximab |
| Enrollment | 25 |
| Start date | May 1, 2003 |
| Completion | Jan 1, 2006 |
| First posted | Aug 8, 2005 |
| Last update posted | Jan 12, 2007 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: